• FAQ
Prophase Logo
open menu
  • About Us
    • About Us
    • Management Team
  • Our Companies
    • Nebula Genomics
    • ProPhase Diagnostics
    • ProPhase Biopharma
    • Pharmaloz Manufacturing
    • TK Supplements
  • Investor Relations
    • Presentations
    • News & Events
      • Press Releases
      • Media Mentions
      • IR Calendar
      • Email Alerts
    • Company Info
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Contact Us
    • Corporate
    • Diagnostics
    • Pharmaloz
    • TKSupplements

Press Releases

Investors

Investors

  • Overview
  • Presentations
  • News & Events
    • Press Releases
    • Media Mentions
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Media Mentions
  • IR Calendar
  • Email Alerts
Mar 08, 2024 8:00am EST

PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024

Feb 20, 2024 8:00am EST

ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART

Feb 14, 2024 8:00am EST

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

Jan 30, 2024 8:00am EST

ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics

Jan 23, 2024 8:00am EST

Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts

Jan 04, 2024 8:00am EST

ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024

Nov 09, 2023 8:00am EST

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

Nov 02, 2023 8:00am EDT

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

Oct 17, 2023 8:00am EDT

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

Oct 12, 2023 8:00am EDT

ProPhase Labs to Present at The ThinkEquity Conference

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …23
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Prophase Logo

© Copyright - ProPhase Labs, Inc.
All Rights Reserved.

  • About Us
  • Our Companies
  • Investor Relations
  • Contact Us
  • Site Map
  • Legal Notice
  • Accessibility